Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (628)	4/27/1999 12:04:00 PM
From: aknahow	Read Replies (1) \| Respond to of 4974

Potential, concept for basket financing of biotechs, development described in posted article. At the moment not being used to provide financing. The potential for financing is only in my imagination, and would be more complex, (prospectus would be required). If the market accepts the present basket security it will be copied, and modifications will be made. Convinced one could be financing tool. Perhaps, two big well known ones with one or two small companies. Except big ones don't need or want financing. But this can be overcome by combo using outstanding stock of the big ones with new stock for the little one that is financing. Sorry, to be running off at the mouth but, this is something we may hear more of. biz.yahoo.com I understand this is a performance tracking security, so they don't need to invest in the companies, but only hedge the risk to assure ability to match plus guarantee return of principal. No matter, the concept, also being tested, is does the market want a small basket, compared to a mutual fund? If they do, the structure can be modified, IMO, to accomodate financing.